Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361439 · ClinicalTrials.gov registry record · Phase 4
Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis
A Phase 4 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT00361439 is a Phase 4 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 17 participants.
The verdict
NCT00361439, a Phase 4 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
People with allergies frequently complain of a loss or reduction in the sense of smell. In this study, the investigators propose to perform a randomized, double blind, placebo controlled parallel study of subjects with nasal allergies and decreased smell to determine the effect of a treatment for allergies on the sense of smell.
Interventions
- DRUG Placebo
- DRUG Mometasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00361439
The ClinicalTrials.gov registry entry for NCT00361439 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00361439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00361439 about?
NCT00361439 is a clinical study titled "Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis". People with allergies frequently complain of a loss or reduction in the sense of smell. In this study, the investigators propose to perform a randomized, double blind, placebo controlled parallel study of subjects with nasal allergies and decreased smell to determine the effect of a treatment for a...
What is the current status of trial NCT00361439?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2006-08. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00361439?
The interventions under investigation include: Placebo (DRUG), Mometasone (DRUG).
Who is sponsoring clinical trial NCT00361439?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.